EAM Investors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-90,079
Closed -$2.19M 403
2023
Q1
$2.19M Sell
90,079
-10,192
-10% -$223K 0.43% 84
2022
Q4
$2.15M Sell
100,271
-51,422
-34% -$1.1M 0.44% 75
2022
Q3
$2.72M Buy
+151,693
New +$1.99M 0.59% 45
2022
Q2
Sell
-155,778
Closed -$2.62M 384
2022
Q1
$2.62M Sell
155,778
-34,235
-18% -$506K 0.49% 65
2021
Q4
$3.18M Sell
190,013
-45,074
-19% -$739K 0.52% 47
2021
Q3
$3.82M Buy
+235,087
New +$2.56M 0.64% 28
2016
Q2
Sell
-48,341
Closed -$2.04M 388
2016
Q1
$2.04M Buy
48,341
+6,342
+15% +$323K 0.32% 152
2015
Q4
$3.3M Buy
+41,999
New +$2.43M 0.43% 88
2015
Q2
Sell
-58,212
Closed -$2.71M 384
2015
Q1
$2.71M Buy
58,212
+97
+0.2% +$5.04K 0.31% 163
2014
Q4
$2.61M Buy
58,115
+19,125
+49% +$803K 0.36% 98
2014
Q3
$1.52M Buy
38,990
+7,058
+22% +$277K 0.31% 133
2014
Q2
$1.35M Buy
+31,932
New +$1.17M 0.26% 194

Other funds holding ISEE

EAM Investors's ISEE Position: Q2 2023 in Review

EAM Investors sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 90,079 shares — an estimated $2.19M sold.

EAM Investors first reported a position in ISEE in Q2 2014 and held it in 12 quarters. The position peaked at $3.82M in Q3 2021. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • EAM Investors reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • EAM Investors sold 90,079 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $2.19M.
  • EAM Investors first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and held it in 12 quarters.
  • EAM Investors's IVERIC bio, Inc. Common Stock position peaked at $3.82M in Q3 2021.
  • 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on EAM Investors's 13F filing for Q2 2023, filed 11 Aug 2023.